Regulatory issues for commercialization of tomatoes with an antisense polygalacturonase gene

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Significant progress has been made in development of transgenic plants containing agriculturally useful genes. Concurrent with scientific advances has been development of a regulatory infrastructure within the U.S. Department of Agriculture (USDA) for assessing safety of controlled release of genetically engineered plants into the environment, as well as creation of a food policy by the Food and Drug Administration (FDA). Field trials and safety assessments of tomato containing an antisense polygalacturonase gene (FLAVR SAVR™ tomato) have been conducted. A detailed safety analysis of the kanr selectable marker was also done. Based on these data plus nutritional measurements, lack of changes in levels of natural toxins, and lack of any unintended changes, we have requested that the USDA and FDA determine that this genetically engineered tomato is safe for release into the environment and human consumption. © 1993, Tissue Culture Association. All rights reserved.

Cite

CITATION STYLE

APA

Redenbaugh, K., Berner, T., Emlay, D., Frankos, B., Hiatt, W., Houck, C., … Wixtrom, R. (1993). Regulatory issues for commercialization of tomatoes with an antisense polygalacturonase gene. In Vitro Cellular & Developmental Biology - Plant, 29(1), 17–26. https://doi.org/10.1007/BF02632234

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free